Total Payments
$16,772
2024 Payments
$1,067
Companies
35
Transactions
598
Medicare Patients
7,986
Medicare Billing
$813,122
Payment Breakdown by Category
Food & Beverage$9,328 (55.6%)
Other$7,030 (41.9%)
Education$413.67 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,328 | 591 | 55.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,030 | 3 | 41.9% |
| Education | $413.67 | 4 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $7,682 | 32 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $3,190 | 181 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,606 | 126 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,408 | 77 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $523.38 | 31 | $0 (2024) |
| GENZYME CORPORATION | $368.49 | 25 | $0 (2024) |
| Mylan Specialty L.P. | $198.98 | 12 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $179.88 | 11 | $0 (2019) |
| Insmed, Inc. | $172.98 | 12 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $154.93 | 12 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,067 | 59 | AstraZeneca Pharmaceuticals LP ($594.49) |
| 2023 | $1,044 | 65 | AstraZeneca Pharmaceuticals LP ($496.15) |
| 2022 | $1,016 | 62 | AstraZeneca Pharmaceuticals LP ($409.31) |
| 2021 | $668.08 | 37 | AstraZeneca Pharmaceuticals LP ($378.35) |
| 2020 | $716.18 | 50 | AstraZeneca Pharmaceuticals LP ($231.91) |
| 2019 | $1,794 | 134 | GlaxoSmithKline, LLC. ($399.49) |
| 2018 | $1,311 | 96 | GlaxoSmithKline, LLC. ($370.13) |
| 2017 | $9,156 | 95 | Genentech USA, Inc. ($7,488) |
All Payment Transactions
598 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Immunology | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $13.99 | General |
| Category: Sleep | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Respiratory | ||||||
| 08/16/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Airway Clearance Device | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Respiratory | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/02/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Respiratory | ||||||
| 07/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,055 | 2,725 | $735,698 | $202,511 |
| 2022 | 13 | 2,204 | 2,932 | $842,063 | $229,830 |
| 2021 | 14 | 2,070 | 2,737 | $781,131 | $220,734 |
| 2020 | 17 | 1,657 | 2,231 | $646,208 | $160,047 |
Total Patients
7,986
Total Services
10,625
Medicare Billing
$813,122
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 680 | 1,164 | $422,908 | $119,181 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 242 | 314 | $77,558 | $22,167 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 104 | $50,648 | $15,779 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $55,100 | $13,035 | 23.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 93 | $31,899 | $9,320 | 29.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 45 | $32,985 | $6,700 | 20.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 69 | $16,560 | $4,265 | 25.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 346 | 373 | $14,701 | $3,142 | 21.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $11,056 | $3,069 | 27.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 222 | 236 | $10,596 | $2,581 | 24.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 108 | 110 | $5,850 | $1,308 | 22.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 79 | 79 | $4,429 | $799.80 | 18.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,023 | $791.23 | 77.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $373.67 | 97.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 655 | 1,067 | $387,321 | $112,269 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 236 | 315 | $77,805 | $21,814 | 28.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 132 | 225 | $77,175 | $19,966 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 143 | 143 | $78,793 | $18,881 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 86 | 106 | $51,622 | $16,393 | 31.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 82 | 83 | $60,839 | $14,209 | 23.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 119 | 205 | $49,200 | $12,498 | 25.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 20 | $14,520 | $3,603 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $13,129 | $3,211 | 24.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 356 | 379 | $14,269 | $3,176 | 22.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 217 | 228 | $9,200 | $2,320 | 25.2% |
About Dr. Frederic Scoopo, MD
Dr. Frederic Scoopo, MD is a Pulmonary Disease healthcare provider based in Summit, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750382818.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederic Scoopo, MD has received a total of $16,772 in payments from pharmaceutical and medical device companies, with $1,067 received in 2024. These payments were reported across 598 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,328).
As a Medicare-enrolled provider, Scoopo has provided services to 7,986 Medicare beneficiaries, totaling 10,625 services with total Medicare billing of $813,122. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Summit, NJ
- Active Since 08/10/2005
- Last Updated 02/03/2017
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1750382818
Products in Payments
- Esbriet (Biological) $7,449
- OFEV (Drug) $792.10
- FASENRA (Biological) $756.98
- DUPIXENT (Biological) $711.43
- BREZTRI (Drug) $510.72
- FASENRA (Drug) $462.29
- SYMBICORT (Drug) $462.18
- TRELEGY ELLIPTA (Drug) $461.83
- NUCALA (Biological) $449.15
- STIOLTO RESPIMAT (Drug) $401.22
- TEZSPIRE (Biological) $388.98
- BEVESPI AEROSPHERE (Drug) $290.49
- BREO (Drug) $285.46
- AIRSUPRA (Drug) $256.38
- Xolair (Biological) $233.93
- ANORO (Drug) $182.27
- Arikayce (Drug) $172.98
- DUPIXENT (Drug) $151.61
- JANUVIA (Drug) $129.42
- Prolastin-C Liquid (Biological) $128.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Summit
Federico Cerrone, M.d, M.D
Pulmonary Disease — Payments: $12,817
Pulmonary Disease $12,817
Christopher Decotiis, Md, MD
Pulmonary Disease — Payments: $6,340
Pulmonary Disease $6,340
Erwin Oei, Md, MD
Pulmonary Disease — Payments: $4,118
Pulmonary Disease $4,118
Edward Dimitry, Md, MD
Pulmonary Disease — Payments: $1,192
Pulmonary Disease $1,192
Chirag Shah, Md, MD
Pulmonary Disease — Payments: $909.09
Pulmonary Disease $909.09
Andrew Toscano, M.d, M.D
Pulmonary Disease — Payments: $760.34
Pulmonary Disease $760.34